Highlights argenx SE

Equities

ARGX

NL0010832176

Market Closed - Euronext Bruxelles Other stock markets 11:37:08 2024-06-06 am EDT			After market 12:54:38 pm
352.8 ^EUR	+0.51%		352.2	-0.16%

May. 30	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	MT
May. 29	European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	May. 30	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading	May. 17	MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Wednesday Trading	May. 15	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	May. 10	MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	May. 09	MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Fading Rate Cut Hopes	May. 09	MT
Europe's STOXX 600 pauses after recent rally; BBVA weighs on Spain	May. 09	RE
Argenx Q1 Loss Widens, Total Operating Income Rises	May. 09	MT
European shares pause after recent rally, BoE decision in focus	May. 09	RE
Argenx SE Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	May. 03	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 17	MT
Argenx SE Announces Data from its Phase 3 ADHERE Trial Evaluating VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy	Apr. 16	CI
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	Apr. 04	MT
Argenx Se Advances Clinical Development of Efgartigimod in Primary Sjogren's Disease	Mar. 27	CI
Argenx SE Announces Approval of Vyvgart (Efgartigimod Alfa) in Japan for Adults with Primary Immune Thrombocytopenia	Mar. 26	CI
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	Mar. 21	MT
US Futures, European Stocks Rise After Fed Maintains Outlook	Mar. 21	DJ
Global markets live: HP, Moncler, Snowflake, Salesforce, Duolingo...	Feb. 29
Argenx Q4 Loss Widens, Revenue Increases -- Shares Down Pre-Bell	Feb. 29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights argenx SE

Equities

ARGX

NL0010832176

Highlights

Filters